Immunotherapy drugs
Use this search tool to find approved immunotherapy drugs. Click on the brand name to learn more about each drug, including what types of cancer it treats, how it works, how well it works, and its possible side effects.
| Brand Name | Drug Name | Clinical Approval |
|---|---|---|
| Tecartus | Brexucabtagene autoleucel | US & EU |
| Kadcyla | Ado-trastuzumab emtansine | US & EU |
| Tecelra | Afamitresgene autoleucel | US |
| Proleukin | Aldesleukin | US |
| Rybrevant | Amivantamab-vmjw | US & EU |
| Tecentriq | Atezolizumab | US & EU |
| Tecentriq Hybreza | Atezolizumab and hyaluronidase-tqjs | US |
| Bavencio | Avelumab | US & EU |
| Yescarta | Axicabtagene ciloleucel | US & EU |
| Blenrep | Belantamab Mafodotin-blmf | US |
| Avastin | Bevacizumab | US & EU |
| Mvasi | Bevacizumab-awwb | US & EU |
| Zirabev | Bevacizumab-bvzr | US & EU |
| Blincyto | Blinatumomab | US & EU |
| Adcetris | Brentuximab Vedotin | US & EU |
| Libtayo | Cemiplimab-rwlc | US & EU |
| Erbitux | Cetuximab | US & EU |
| Carvykti | Ciltacabtagene autoleucel | US & EU |
| Unloxcyt | Cosibelimab-ipdl | US |
| Darzalex | Daratumumab | US & EU |
| Darzalex Faspro | Daratumumab and hyaluronidase-fihj | US |
| Unituxin | Dinutuximab | US |
| Qarziba | Dinutuximab beta | EU |
| Jemperli | Dostarlimab-gxly | US & EU |
| Imfinzi | Durvalumab | US & EU |
| Empliciti | Elotuzumab | US & EU |
| Elrexfio | Elranatamab-bcmm | US & EU |
| Padcev | Enfortumab Vedotin-ejfv | US & EU |
| Epkinly | Epcoritamab-bysp | US |
| Tepkinly | Epcoritamab-bysp | EU |
| Enhertu | Fam-trastuzumab deruxtecan-nxki | US & EU |
| Mylotarg | Gemtuzumab Ozogamicin | US & EU |
| Columvi | Glofitamab-gxbm | US & EU |
| Abecma | Idecabtagene Vicleucel | US & EU |
| Besponsa | Inotuzumab Ozogamicin | US & EU |
| Yervoy | Ipilimumab | US & EU |
| Sarclisa | Isatuximab-irfc | US & EU |
| Amtagvi | Lifileucel | US |
| Breyanzi | Lisocabtagene Maraleucel | US & EU |
| Zynlonta | Loncastuximab tesirine-lpy | US & EU |
| Margenza | Margetuximab-cmkb | US |
| Elahere | Mirvetuximab soravtansine-gynx | US & EU |
| Poteligeo | Mogamulizumab | US & EU |
| Lunsumio | Mosunetuzumab-axgb | US & EU |
| Adstiladrin | Nadofaragene firadenovec-vncg | US |
| Danyelza | Naxitamab | US |
| Portrazza | Necitumumab | US |
| Opdivo | Nivolumab | US & EU |
| Opdualag | Nivolumab and relatlimab-rmbw | US & EU |
| Opdivo Qvantig | Nivolumab plus hyaluronidase | US |
| Anktiva | Nogapendekin alfa inbakicept-pmln | US |
| Gazyvaro | Obinutuzumab | EU |
| Gazyva | Obinutuzumab | US |
| Vectibix | Panitumumab | US & EU |
| Keytruda | Pembrolizumab | US & EU |
| Perjeta | Pertuzumab | US & EU |
| Phesgo | Pertuzumab, Trastuzumab, hyaluronidase-zzxf combination | US & EU |
| Polivy | Polatuzumab Vedotin-Piiq | US & EU |
| Cyramza | Ramucirumab | US & EU |
| Zynyz | Retifanlimab-dlwr | US |
| Blitzima | Rituximab | EU |
| Riximyo | Rituximab | EU |
| Rituxan | Rituximab | US |
| MabThera | Rituximab | EU |
| Rixathon | Rituximab | EU |
| Truxima | Rituximab-abbs | US & EU |
| Trodelvy | Sacituzumab Govitecan-hziy | US & EU |
| Sylvant | Siltuximab | US & EU |
| Provenge | Sipuleucel-T | US |
| Minjuvi | Tafasitamab | EU |
| Monjuvi | Tafasitamab-cxix | US |
| Elzonris | Tagraxofusp-erzs | US & EU |
| Imlygic | Talimogene laherparepvec | US & EU |
| Talvey | Talquetamab-tgvs | US & EU |
| Imdelltra | Tarlatamab-dlle | US |
| Kimmtrak | Tebentafusp-tebn | US & EU |
| Tecvayli | Teclistamab-cpyv | US & EU |
| Kymriah | Tisagenlecleucel | US & EU |
| Tivdak | Tisotumab Vedotin-tftv | US |
| Loqtorzi | Toripalimab-tpzi | US |
| Zercepac | Trastuzumab | EU |
| Kanjinti | Trastuzumab | US & EU |
| Ogivri | Trastuzumab | US & EU |
| Ontruzant | Trastuzumab | US & EU |
| Herzuma | Trastuzumab | US & EU |
| Trazimera | Trastuzumab | US & EU |
| Herceptin | Trastuzumab | US & EU |
| Herceptin Hylecta | Trastuzumab and Hyaluronidase | US |
| Imjudo | Tremelimumab-actl | US & EU |
| Zaltrap | ziv-Aflibercept | US & EU |
